Socorro Shelton, Dois Ogan, Timothy Cox, Jordyn Drake, Nicole Wakimoto
{"title":"对于急性呼吸窘迫综合征(ARDS)患者,干细胞治疗与标准护理相比,是否能减少通气天数和死亡率?","authors":"Socorro Shelton, Dois Ogan, Timothy Cox, Jordyn Drake, Nicole Wakimoto","doi":"10.1097/ebp.0000000000002093","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":12164,"journal":{"name":"Evidence-Based Practice","volume":"150 2","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"In patients with acute respiratory distress syndrome (ARDS), does stem cell treatment versus standard of care reduce days of ventilation and mortality?\",\"authors\":\"Socorro Shelton, Dois Ogan, Timothy Cox, Jordyn Drake, Nicole Wakimoto\",\"doi\":\"10.1097/ebp.0000000000002093\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":12164,\"journal\":{\"name\":\"Evidence-Based Practice\",\"volume\":\"150 2\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-02-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Evidence-Based Practice\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/ebp.0000000000002093\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Nursing\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Evidence-Based Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/ebp.0000000000002093","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Nursing","Score":null,"Total":0}
In patients with acute respiratory distress syndrome (ARDS), does stem cell treatment versus standard of care reduce days of ventilation and mortality?